A case of subacute thyroiditis in a patient on adalimumab for treatment of refractory palmo-plantar psoriasis

A case of subacute thyroiditis in a patient on adalimumab for treatment of refractory palmo-plantar psoriasis

Recent reports indicate different side-effects of the new medication for psoriasis. Adalimumab. Adalimumab is a biologic agent acting as tumor necrosis factor alpha inhibitor. It is wildly used in treating psoriasis, following a national guide treatment. We report a clinical case of subacute thyroid...

Full description

Bibliographic Details
Main Authors: Anca Chiriac, Liliana Foia, Anca E Chiriac, Vlad E Gorduza, Caius Solovan, Piotr Brzezinski
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Muller Journal of Medical Sciences and Research
Subjects:
Adalimumab
psoriasis
thyroiditis
tumor necrosis factor alpha
Online Access:http://www.mjmsr.net/article.asp?issn=0975-9727;year=2014;volume=5;issue=1;spage=70;epage=73;aulast=Chiriac

Internet

http://www.mjmsr.net/article.asp?issn=0975-9727;year=2014;volume=5;issue=1;spage=70;epage=73;aulast=Chiriac

Similar Items